Sonia Di Gaetano

Dr. Sonia Di Gaetano

CNR - IBB, Naples, Campania, Italy
orcid
Researcher

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Biochemical Pharmacology
Verified
Journal Article
Closed access
FFFederica Finetti
Federica Finetti
ABAnna Basile
Anna Basile
Domenica CapassoDomenica Capasso
Domenica Capasso
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
RSRossella Di Stasi
Rossella Di Stasi
LDLuca D'andrea
Luca D'andrea

20 April 2016 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
KPKATIA PANE
KATIA PANE
VSValeria Sgambati
Valeria Sgambati
AZAnna Zanfardino
Anna Zanfardino
Giovanni SmaldoneGiovanni Smaldone
Giovanni Smaldone
VCValeria Cafaro
Valeria Cafaro
EPElio Pizzo
Elio Pizzo

14 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Giovanni SmaldoneGiovanni Smaldone
Giovanni Smaldone
Luciano PironeLuciano Pirone
Luciano Pirone
NBNicole Balasco
Nicole Balasco
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
Emilia PedoneEmilia Pedone
Emilia Pedone
Luigi VitaglianoLuigi Vitagliano
Luigi Vitagliano
Cullin 3 (Cul3) recognition by BTB domains is a key process in protein ubiquitination. Among Cul3 binders, a great attention is currently devoted to KCTD proteins, which are implicated in fundamental biological processes. On the basis of the high similarity of BTB domains of these proteins, it has been suggested that the ability to bind Cul3 could be a general property among all KCTDs. In order to gain new insights into KCTD functionality, we here evaluated and/or quantified the binding of Cul3 to the BTB of KCTD proteins, which are known to be involved either in cullin-independent (KCTD12 and KCTD15) or in cullin-mediated (KCTD6 and KCTD11) activities. Our data indicate that KCTD6BTB and KCTD11BTB bind Cul3 with high affinity forming stable complexes with 4:4 stoichiometries. Conversely, KCTD12BTB and KCTD15BTB do not interact with Cul3, despite the high level of sequence identity with the BTB domains of cullin binding KCTDs. Intriguingly, comparative sequence analyses indicate that the capability of KCTD proteins to recognize Cul3 has been lost more than once in distinct events along the evolution. Present findings also provide interesting clues on the structural determinants of Cul3-KCTD recognition. Indeed, the characterization of a chimeric variant of KCTD11 demonstrates that the swapping of α2β3 loop between KCTD11BTB and KCTD12BTB is sufficient to abolish the ability of KCTD11BTB to bind Cul3. Finally, present findings, along with previous literature data, provide a virtually complete coverage of Cul3 binding ability of the members of the entire KCTD family.

7 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CAConcetta Avitabile
Concetta Avitabile
LMLoredana Moggio
Loredana Moggio
GMGaetano Malgieri
Gaetano Malgieri
Domenica CapassoDomenica Capasso
Domenica Capasso
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
ARAlessandra Romanelli
Alessandra Romanelli
Peptide Nucleic Acids (PNAs), nucleic acid analogues showing high stability to enzyme degradation and strong affinity and specificity of binding toward DNA and RNA are widely investigated as tools to interfere in gene expression. Several studies have been focused on PNA analogues with modifications on the backbone and bases in the attempt to overcome solubility, uptake and aggregation issues. γ PNAs, PNA derivatives having a substituent in the γ position of the backbone show interesting properties in terms of secondary structure and affinity of binding toward complementary nucleic acids. In this paper we illustrate our results obtained on new analogues, bearing a sulphate in the γ position of the backbone, developed to be more DNA-like in terms of polarity and charge. The synthesis of monomers and oligomers is described. NMR studies on the conformational properties of monomers and studies on the secondary structure of single strands and triplexes are reported. Furthermore the hybrid stability and the effect of mismatches on the stability have also been investigated. Finally, the ability of the new analogue to work as antigene, interfering with the transcription of the ErbB2 gene on a human cell line overexpressing ErbB2 (SKBR3), assessed by FACS and qPCR, is described.

1 April 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SRSara Raimondi
Sara Raimondi
FGFulvio Guglielmi
Fulvio Guglielmi
SGSofia Giorgetti
Sofia Giorgetti
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
Angela ArcielloAngela Arciello
Angela Arciello
VBVittorio Bellotti
Vittorio Bellotti

6 July 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RPRenata Piccoli
Renata Piccoli
Sonia Di GaetanoSonia Di Gaetano
Sonia Di Gaetano
Claudia De LorenzoClaudia De Lorenzo
Claudia De Lorenzo
MGMichela Grauso
Michela Grauso
CMCarmen Monaco
Carmen Monaco
GDGiuseppe D’aLessio
Giuseppe D’aLessio
Monomeric human pancreatic RNase, devoid of any biological activity other than its RNA degrading ability, was engineered into a dimeric protein with a cytotoxic action on mouse and human tumor cells, but lacking any appreciable toxicity on mouse and human normal cells. This dimeric variant of human pancreas RNase selectively sensitizes to apoptotic death cells derived from a human thyroid tumor. Because of its selectivity for tumor cells, and because of its human origin, this protein represents a potentially very attractive, novel tool for anticancer therapy.